Rizintug 75

THERAPY INDICATIONS:
- Treatment of symptoms of labyrinthine disorders, including dizziness, lightheadedness, tinnitus, nystagmus, nausea, vomiting.

- Prophylaxis of migraine.

- Maintenance treatment of symptoms of cerebrovascular origin, including: dizziness, tinnitus, vascular headache, social dissociation, and disturbances of arousal, memory loss and poor concentration.

- Maintenance treatment of symptoms of peripheral circulatory disorders, including Raynaud's phenomenon, acrocyanosis, claudication, trophic disorders, varicose ulcers, paresthesia, nocturnal muscle spasms, cold extremities.

CONTRAINDICATIONS:
Patients with hypersensitivity to cinnarizine or to any ingredient of the drug.

HOW TO USE:
The medicine should be taken after meals.
The dose should not exceed 225 mg/day.